Dr. Gregg E. Franklin, MD

Dr. Franklin practices at Surgical Specialty Care in Albuquerque, New Mexico.

Dr. Franklin's NPI, 1124018353, was assigned on October 27, 2005. Dr. Franklin holds New Mexico license 2005-0441.

Dr. Franklin's primary practice is Surgical Specialty Care, at 4901 Lang Ave Ne, Albuquerque, NM 87109. The practice phone is (505) 842-8171.

Dr. Franklin's primary practice is Surgical Specialty Care in Albuquerque, New Mexico. Dr. Franklin is also affiliated with Lovelace Medical Center. The medical group on file is New Mexico Cancer Center (NMCC). Dmand AI also links Dr. Franklin to 1 more group practice or clinic and 1 therapy and rehab clinic, each named with a free account. Dr. Franklin's employer is on file too: a surgery center (asc).

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Franklin practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Franklin's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Franklin is licensed in New Mexico.

CMS data shows 9,093 Medicare services from Dr. Franklin across 26 procedure codes in 2024, for 290 Medicare patients. Medicare paid $1,731,213 for them. Every service was in an office.

CMS counts 290 Medicare patients who saw Dr. Franklin in 2024. The largest group is 65 to 74, with 158 patients. 75% of them have cancer, and 66% have high blood pressure. 13% are also on Medicaid. Their average risk score is 1.71, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Franklin's median patient age at 71, with 46% women.

In 2024, Dr. Franklin wrote 255 Medicare Part D claims for 91 patients. 96% of them were for generic drugs. CMS names the drug for 130 of them, across 4 drugs with 11 or more claims each, at $2,413 in total drug cost. In 2023, CMS named 134 claims across 6 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 89 out of 100 for Dr. Franklin for performance year 2024, reported as part of a group. Dr. Franklin accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 5 papers to Dr. Franklin, published from 2015 to 2021. 2015 was the busiest year, with 2. Dr. Franklin's most frequent co-authors are Bryan J. Schneider, MD, Edward P. Balaban, DO and Elizabeth M. Blanchard, MD.

Dmand AI links Dr. Franklin to 3 clinical trials, 2 of them phase 3 studies. 1 is still active or recruiting. Conditions studied include Prostatic Neoplasms and Prostatic Diseases. Open Payments lists research payments to Dr. Franklin that name 1 trial.

CMS Open Payments shows 276 general payments to Dr. Franklin from 55 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 44% of the total. Bayer HealthCare Pharmaceuticals Inc. paid the most, $92,198. It also lists 1 research payment totaling $1,017 in 2025, naming 1 clinical trial.